Alliance for Regenerative Medicine

Search ARM

We are the leading international advocacy organization championing the benefits of engineered cell therapies and genetic medicines for patients, healthcare systems, and society.

Learn More

Become a Member

Save the dates for the Cell and Gene Meeting on the Mesa!

The meeting, which runs from October 10-12, takes place in Carlsbad, California, with virtual attendance options for registrants who can’t make it in person. Registration is open! Learn more!

Looking for updates on future ARM events? Sign up for our email list here!

Featured

ARM is hiring!

Looking for a new career? ARM is hiring an Executive Assistant and a Director, Access and Reimbursement Policy. Click on the link below to learn more about the positions and how to apply.

APPLY TODAY

Featured

Announcing our August 2023 Sector Snapshot and new data format

Announcing our latest Sector Snapshot! Dive into how industry leaders think we should address workforce challenges in the cell and gene therapy sector. Our snapshot also includes a look at the latest sector data and an updated regulatory pipeline.

READ THE SECTOR SNAPSHOT
VIEW THE LATEST SECTOR DATA

Featured

Proposed joint clinical assessment methodology would have rejected nearly 90% of the ATMPs currently authorized in the EU

Without changes recognizing the unique characteristics of ATMPs, the EU’s new Joint Clinical Assessment (JCA) will fail to deliver the next generation of transformative therapies to rare disease patients. ARM has issued a call to action to modernize the JCA methodology so it can deliver life-changing therapies to patients.

READ THE RELEASE

Featured

Addressing potency-assay related development delays for cell and gene therapies

The Alliance for Regenerative Medicine and the American Society for Cell and Gene Therapy released a report addressing potency-assay related development delays for cell and gene therapies, in response to an October 19 meeting with regulators and other concerned parties.

READ THE RELEASE

Featured

ARM Releases its Workforce Report: Gap Analysis for the Cell and Gene Therapy Sector

The Alliance for Regenerative Medicine released its Workforce Report: Gap Analysis for the Cell and Gene Therapy Sector. This report provides a landscape overview and gap analysis of the workforce needed for sustainable biomanufacturing of cell and gene therapies in the United States.

READ THE REPORT

Learn About Regenerative Medicine

Regenerative medicine includes gene therapies, cell therapies, and tissue-engineered products intended to augment, repair, replace, or regenerate organs, tissues, cells, genes, and metabolic processes in the body.

Regenerative medicine aims to alter the current practice of medicine by treating the root causes of disease and disorders.

FIND OUT MORE

Discover the Alliance

ARM takes the lead on the most important issues facing the regenerative medicine and advanced therapy sector today:

Advocating for clear, predictable and harmonized regulatory and review pathways
Enabling market access and value-based reimbursement policies
Addressing industrialization and manufacturing hurdles
Conducting key stakeholder outreach, communication and education
Facilitating sustainable access to capital and identify sources of potential public funding.

Find Out More

Explore How ARM Leads the Way

As the global voice of the sector, we represent more than 400 members across 25 countries, including emerging and established biotechnology companies, academic and medical research institutions, and patient organizations.

FIND OUT MORE

Stay Connected

Newsletter Sign Up Twitter LinkedIn